Shedding of Gal-9 from the surfaces of leukemic cells has been well-documented in studies on AML, where extracellular Gal-9 has been shown to activate TIM-3 signalling pathways, including in NK cells [51,52]. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.